Financials ProSomnus, Inc.

Equities

OSAPQ

US50535E1082

Advanced Medical Equipment & Technology

Delayed OTC Markets 09:30:02 2024-06-21 am EDT 5-day change 1st Jan Change
0.01 USD -15.97% Intraday chart for ProSomnus, Inc. 0.00% -98.98%

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 69.96 89.23 16.07
Enterprise Value (EV) 1 82.64 106.4 51.08
P/E ratio -40.3 x -7.8 x -0.66 x
Yield - - -
Capitalization / Revenue 4.97 x 4.6 x 0.58 x
EV / Revenue 5.87 x 5.49 x 1.85 x
EV / EBITDA -20.7 x -9.63 x -2.97 x
EV / FCF -20,476,230 x -11,112,337 x -5,440,978 x
FCF Yield -0% -0% -0%
Price to Book -4.58 x -4.35 x -0.45 x
Nbr of stocks (in thousands) 7,095 16,048 16,399
Reference price 2 9.860 5.560 0.9802
Announcement Date 11/15/22 4/14/23 3/27/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 8.286 14.07 19.39 27.65
EBITDA 1 -3.585 -3.987 -11.05 -17.18
EBIT 1 -4.158 -4.815 -11.48 -19.11
Operating Margin -50.18% -34.21% -59.17% -69.09%
Earnings before Tax (EBT) 1 -6.155 -5.97 -7.145 -24.1
Net income 1 -6.173 -5.977 -7.145 -24.1
Net margin -74.5% -42.47% -36.84% -87.14%
EPS 2 -0.2575 -0.2449 -0.7130 -1.489
Free Cash Flow - -4.036 -9.574 -9.388
FCF margin - -28.67% -49.37% -33.95%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 11/15/22 11/15/22 4/14/23 3/27/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 5.808 6.934 7.071 7.838
EBITDA 1 -3.977 -5.542 -3.998 -4.61
EBIT 1 -4.144 -5.736 -4.216 -5.01
Operating Margin -71.35% -82.72% -59.62% -63.92%
Earnings before Tax (EBT) 1 -6.892 0.9049 -11.24 -6.869
Net income 1 -6.892 0.9049 -11.24 -6.869
Net margin -118.66% 13.05% -158.93% -87.63%
EPS 2 -0.4300 0.0473 -0.7000 -0.4200
Dividend per Share - - - -
Announcement Date 5/9/23 8/3/23 11/9/23 3/27/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 8.66 12.7 17.2 35
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) -2.414 x -3.179 x -1.553 x -2.038 x
Free Cash Flow - -4.04 -9.57 -9.39
ROE (net income / shareholders' equity) - 53.3% 41.4% 102%
ROA (Net income/ Total Assets) - -43% -35.1% -40.1%
Assets 1 - 13.9 20.34 60.02
Book Value Per Share 2 -1.970 -2.150 -1.280 -2.190
Cash Flow per Share 2 0.0600 0.0600 0.9900 0.3700
Capex 1 0.09 0.3 1.35 1.47
Capex / Sales 1.03% 2.14% 6.98% 5.31%
Announcement Date 11/15/22 11/15/22 4/14/23 3/27/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. OSAPQ Stock
  4. Financials ProSomnus, Inc.